260 related articles for article (PubMed ID: 31733128)
1. An NMR based panorama of the heterogeneous biology of acute respiratory distress syndrome (ARDS) from the standpoint of metabolic biomarkers.
Viswan A; Singh C; Kayastha AM; Azim A; Sinha N
NMR Biomed; 2020 Feb; 33(2):e4192. PubMed ID: 31733128
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia.
Viswan A; Singh C; Rai RK; Azim A; Sinha N; Baronia AK
PLoS One; 2017; 12(11):e0187545. PubMed ID: 29095932
[TBL] [Abstract][Full Text] [Related]
3. Distinct Metabolic Endotype Mirroring Acute Respiratory Distress Syndrome (ARDS) Subphenotype and its Heterogeneous Biology.
Viswan A; Ghosh P; Gupta D; Azim A; Sinha N
Sci Rep; 2019 Feb; 9(1):2108. PubMed ID: 30765824
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics profile in acute respiratory distress syndrome by nuclear magnetic resonance spectroscopy in patients with community-acquired pneumonia.
Yan Y; Chen J; Liang Q; Zheng H; Ye Y; Nan W; Zhang X; Gao H; Li Y
Respir Res; 2022 Jun; 23(1):172. PubMed ID: 35761396
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics: An emerging potential approach to decipher critical illnesses.
Siddiqui MA; Pandey S; Azim A; Sinha N; Siddiqui MH
Biophys Chem; 2020 Dec; 267():106462. PubMed ID: 32911125
[TBL] [Abstract][Full Text] [Related]
6. Lung Metabolic Activation as an Early Biomarker of Acute Respiratory Distress Syndrome and Local Gene Expression Heterogeneity.
Wellman TJ; de Prost N; Tucci M; Winkler T; Baron RM; Filipczak P; Raby B; Chu JH; Harris RS; Musch G; Dos Reis Falcao LF; Capelozzi V; Venegas JG; Vidal Melo MF
Anesthesiology; 2016 Nov; 125(5):992-1004. PubMed ID: 27611185
[TBL] [Abstract][Full Text] [Related]
7. [Research progress of vitamin metabolomics in acute respiratory distress syndrome].
He Z; Xu F
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Oct; 33(10):1262-1265. PubMed ID: 34955141
[TBL] [Abstract][Full Text] [Related]
8. Systems Biology ARDS Research with a Focus on Metabolomics.
Metwaly SM; Winston BW
Metabolites; 2020 May; 10(5):. PubMed ID: 32438561
[TBL] [Abstract][Full Text] [Related]
9. Applying metabolomics to uncover novel biology in ARDS.
Rogers AJ; Matthay MA
Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(11):L957-61. PubMed ID: 24727586
[TBL] [Abstract][Full Text] [Related]
10. Explore potential plasma biomarkers of acute respiratory distress syndrome (ARDS) using GC-MS metabolomics analysis.
Lin S; Yue X; Wu H; Han TL; Zhu J; Wang C; Lei M; Zhang M; Liu Q; Xu F
Clin Biochem; 2019 Apr; 66():49-56. PubMed ID: 30779905
[TBL] [Abstract][Full Text] [Related]
11. A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress Syndrome.
Blondonnet R; Constantin JM; Sapin V; Jabaudon M
Dis Markers; 2016; 2016():3501373. PubMed ID: 26980924
[TBL] [Abstract][Full Text] [Related]
12. [Research progress on metabolomics of acute respiratory distress syndrome].
Duan X; Xu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):434-439. PubMed ID: 35692213
[TBL] [Abstract][Full Text] [Related]
13. Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health.
Evans CR; Karnovsky A; Kovach MA; Standiford TJ; Burant CF; Stringer KA
J Proteome Res; 2014 Feb; 13(2):640-9. PubMed ID: 24289193
[TBL] [Abstract][Full Text] [Related]
14. Evolution of ARDS biomarkers: Will metabolomics be the answer?
Metwaly S; Cote A; Donnelly SJ; Banoei MM; Mourad AI; Winston BW
Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L526-L534. PubMed ID: 29952222
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics Study Revealing Purines as Potential Diagnostic Biomarkers of Acute Respiratory Distress Syndrome in Patients with Community─Acquired Pneumonia.
Xiong F; Jiang K; Chen J; Yan Y; Zhou Y; Chen Z; Zheng H; Li Y; Gao H
J Proteome Res; 2023 Aug; 22(8):2558-2569. PubMed ID: 37432907
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality.
van der Zee P; Rietdijk W; Somhorst P; Endeman H; Gommers D
Crit Care; 2020 May; 24(1):243. PubMed ID: 32448370
[TBL] [Abstract][Full Text] [Related]
17. ARDS metabolic fingerprints: characterization, benchmarking, and potential mechanistic interpretation.
Metwaly S; Côté A; Donnelly SJ; Banoei MM; Lee CH; Andonegui G; Yipp BG; Vogel HJ; Fiehn O; Winston BW
Am J Physiol Lung Cell Mol Physiol; 2021 Jul; 321(1):L79-L90. PubMed ID: 33949201
[TBL] [Abstract][Full Text] [Related]
18. Personalized medicine using omics approaches in acute respiratory distress syndrome to identify biological phenotypes.
Battaglini D; Al-Husinat L; Normando AG; Leme AP; Franchini K; Morales M; Pelosi P; Rocco PR
Respir Res; 2022 Nov; 23(1):318. PubMed ID: 36403043
[TBL] [Abstract][Full Text] [Related]
19. Metabolic signatures of acute respiratory distress syndrome: COVID versus non-COVID.
Ji X; Ji HL
Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L596-L603. PubMed ID: 38469648
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
